Sumitomo Mitsui DS Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,250
Closed -$798K – 781
2022
Q3
$798K Buy
3,250
+472
+17% +$127K 0.02% 544
2022
Q2
$688K Buy
2,778
+26
+0.9% +$7.02K 0.02% 570
2022
Q1
$912K Buy
2,752
+25
+0.9% +$7.7K 0.02% 537
2021
Q4
$979K Sell
2,727
-20
-0.7% -$6.76K 0.02% 538
2021
Q3
$894K Sell
2,747
-20
-0.7% -$6.78K 0.02% 532
2021
Q2
$863K Hold
2,767
– – 0.02% 538
2021
Q1
$881K Hold
2,767
– – 0.02% 520
2020
Q4
$897K Sell
2,767
-12
-0.4% -$3.32K 0.03% 489
2020
Q3
$769K Buy
2,779
+39
+1% +$11.2K 0.02% 482
2020
Q2
$661K Buy
2,740
+36
+1% +$7.23K 0.02% 504
2020
Q1
$392K Sell
2,704
-58
-2% -$9.63K 0.02% 551
2019
Q4
$471K Sell
2,762
-15
-0.5% -$2.78K 0.02% 601
2019
Q3
$494K Buy
2,777
+449
+19% +$97.1K 0.02% 564
2019
Q2
$606K Sell
2,328
-10,733
-82% -$2.85M 0.02% 507
2019
Q1
$3.73M Sell
13,061
-1,015
-7% -$337K 0.06% 239
2018
Q4
$4.58M Sell
14,076
-1,221
-8% -$424K 0.08% 186
2018
Q3
$6.88M Sell
15,297
-3,792
-20% -$1.49M 0.11% 158
2018
Q2
$7.81M Sell
19,089
-2,328
-11% -$843K 0.12% 144
2018
Q1
$6.23M Buy
21,417
+29
+0.1% +$7.35K 0.09% 170
2017
Q4
$4.01M Buy
+21,388
New +$3.99M 0.06% 242

Other funds holding ABMD

Sumitomo Mitsui DS Asset Management's ABMD Position: Q4 2022 in Review

Sumitomo Mitsui DS Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,250 shares — an estimated $798K sold.

Sumitomo Mitsui DS Asset Management first reported a position in ABMD in Q4 2017 and held it in 20 quarters. The position peaked at $7.81M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Sumitomo Mitsui DS Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 3,250 Abiomed Inc shares in Q4 2022, an estimated $798K.
  • Sumitomo Mitsui DS Asset Management first reported a position in Abiomed Inc in Q4 2017 and held it in 20 quarters.
  • Sumitomo Mitsui DS Asset Management's Abiomed Inc position peaked at $7.81M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q4 2022, filed 26 Jan 2023.